/
CLCS
$0.81-$0.02 (-2.41%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.27 – $2.25
27% from low
Exchange
OTC Link
CS
Borrow rate
9.90%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-0.47
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $407 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | −$407 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $1.5M | $725.1K | $2.6M | $998.6K | $1.3M | $2.0M | $1.6M | $1.9M |
| Operating income | −$2.3M | −$2.0M | −$3.8M | −$3.6M | −$4.0M | −$4.2M | −$4.3M | −$3.8M |
| EBITDA | −$2.3M | −$2.0M | −$460.0K | $301.25B | −$93.0K | $0 | −$4.2M | −$3.6M |
| Net income | −$3.1M | −$2.1M | −$4.5M | −$4.6M | −$5.5M | −$5.2M | −$5.3M | −$4.8M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -0.12 | -0.08 | -0.18 | -0.19 | -0.19 | -0.18 | -0.17 | -0.15 |
Annual figures · source: Financial Modeling Prep
Peer comparison
CELL SOURCE INC
CELL SOURCE INC
Held by traders on TradeandTell
No one on the platform currently holds CLCS.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in CLCS as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded CLCS yet.